Global Macrolide Antibiotics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156266
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Macrolide antibiotics are a particular type of antibiotic used to treat, and sometimes prevent, a wide variety of bacterial infections. Macrolide antibiotics stop bacteria multiplying by preventing them from being able to produce proteins that are essential for their growth. The bacteria eventually die or are killed by your immune system.

Scope of the Report:

This report focuses on the Macrolide Antibiotics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Macrolide antibiotics are used to treat infections caused by Gram-positive bacteria (e.g., Streptococcus pneumoniae) and limited Gram-negative bacteria (e.g., Bordetella pertussis, Haemophilus influenzae), and some respiratory tract and soft-tissue infections. The antimicrobial spectrum of macrolides is slightly wider than that of penicillin, and, therefore, macrolides are a common substitute for patients with a penicillin allergy.

The worldwide market for Macrolide Antibiotics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Merck

Pfizer

Teva Pharmaceutical Industries

Fresenius Kabi

Sandoz International

Macrolide Pharmaceuticals

Neo Química

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Azithromycin

Clarithromycin

Erythromycin

Fidaxomicin

Telithromycin

Market Segment by Applications, can be divided into

Hospitals

Dermatology Clinics

Pharmaceutical Companies

There are 15 Chapters to deeply display the global Macrolide Antibiotics market.

Chapter 1, to describe Macrolide Antibiotics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Macrolide Antibiotics, with sales, revenue, and price of Macrolide Antibiotics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Macrolide Antibiotics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Macrolide Antibiotics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Macrolide Antibiotics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Macrolide Antibiotics Introduction

1.2 Market Analysis by Type

1.2.1 Azithromycin

1.2.2 Clarithromycin

1.2.3 Erythromycin

1.2.4 Fidaxomicin

1.2.5 Telithromycin

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Dermatology Clinics

1.3.3 Pharmaceutical Companies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Macrolide Antibiotics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Pfizer

2.2.1 Business Overview

2.2.2 Macrolide Antibiotics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pfizer Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva Pharmaceutical Industries

2.3.1 Business Overview

2.3.2 Macrolide Antibiotics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Industries Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Fresenius Kabi

2.4.1 Business Overview

2.4.2 Macrolide Antibiotics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Fresenius Kabi Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sandoz International

2.5.1 Business Overview

2.5.2 Macrolide Antibiotics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sandoz International Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Macrolide Pharmaceuticals

2.6.1 Business Overview

2.6.2 Macrolide Antibiotics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Macrolide Pharmaceuticals Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Neo Química

2.7.1 Business Overview

2.7.2 Macrolide Antibiotics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Neo Química Macrolide Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Macrolide Antibiotics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Macrolide Antibiotics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Macrolide Antibiotics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Macrolide Antibiotics Manufacturer Market Share in 2017

3.3.2 Top 6 Macrolide Antibiotics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Macrolide Antibiotics Market Analysis by Regions

4.1 Global Macrolide Antibiotics Sales, Revenue and Market Share by Regions

4.1.1 Global Macrolide Antibiotics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Macrolide Antibiotics Revenue and Market Share by Regions (2013-2018)

4.2 North America Macrolide Antibiotics Sales and Growth Rate (2013-2018)

4.3 Europe Macrolide Antibiotics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Macrolide Antibiotics Sales and Growth Rate (2013-2018)

4.5 South America Macrolide Antibiotics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Macrolide Antibiotics Sales and Growth Rate (2013-2018)

5 North America Macrolide Antibiotics by Countries

5.1 North America Macrolide Antibiotics Sales, Revenue and Market Share by Countries

5.1.1 North America Macrolide Antibiotics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Macrolide Antibiotics Revenue and Market Share by Countries (2013-2018)

5.2 United States Macrolide Antibiotics Sales and Growth Rate (2013-2018)

5.3 Canada Macrolide Antibiotics Sales and Growth Rate (2013-2018)

5.4 Mexico Macrolide Antibiotics Sales and Growth Rate (2013-2018)

6 Europe Macrolide Antibiotics by Countries

6.1 Europe Macrolide Antibiotics Sales, Revenue and Market Share by Countries

6.1.1 Europe Macrolide Antibiotics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Macrolide Antibiotics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Macrolide Antibiotics Sales and Growth Rate (2013-2018)

6.3 UK Macrolide Antibiotics Sales and Growth Rate (2013-2018)

6.4 France Macrolide Antibiotics Sales and Growth Rate (2013-2018)

6.5 Russia Macrolide Antibiotics Sales and Growth Rate (2013-2018)

6.6 Italy Macrolide Antibiotics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Macrolide Antibiotics by Countries

7.1 Asia-Pacific Macrolide Antibiotics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Macrolide Antibiotics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Macrolide Antibiotics Revenue and Market Share by Countries (2013-2018)

7.2 China Macrolide Antibiotics Sales and Growth Rate (2013-2018)

7.3 Japan Macrolide Antibiotics Sales and Growth Rate (2013-2018)

7.4 Korea Macrolide Antibiotics Sales and Growth Rate (2013-2018)

7.5 India Macrolide Antibiotics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Macrolide Antibiotics Sales and Growth Rate (2013-2018)

8 South America Macrolide Antibiotics by Countries

8.1 South America Macrolide Antibiotics Sales, Revenue and Market Share by Countries

8.1.1 South America Macrolide Antibiotics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Macrolide Antibiotics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Macrolide Antibiotics Sales and Growth Rate (2013-2018)

8.3 Argentina Macrolide Antibiotics Sales and Growth Rate (2013-2018)

8.4 Colombia Macrolide Antibiotics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Macrolide Antibiotics by Countries

9.1 Middle East and Africa Macrolide Antibiotics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Macrolide Antibiotics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Macrolide Antibiotics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Macrolide Antibiotics Sales and Growth Rate (2013-2018)

9.3 UAE Macrolide Antibiotics Sales and Growth Rate (2013-2018)

9.4 Egypt Macrolide Antibiotics Sales and Growth Rate (2013-2018)

9.5 Nigeria Macrolide Antibiotics Sales and Growth Rate (2013-2018)

9.6 South Africa Macrolide Antibiotics Sales and Growth Rate (2013-2018)

10 Global Macrolide Antibiotics Market Segment by Type

10.1 Global Macrolide Antibiotics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Macrolide Antibiotics Sales and Market Share by Type (2013-2018)

10.1.2 Global Macrolide Antibiotics Revenue and Market Share by Type (2013-2018)

10.2 Azithromycin Sales Growth and Price

10.2.1 Global Azithromycin Sales Growth (2013-2018)

10.2.2 Global Azithromycin Price (2013-2018)

10.3 Clarithromycin Sales Growth and Price

10.3.1 Global Clarithromycin Sales Growth (2013-2018)

10.3.2 Global Clarithromycin Price (2013-2018)

10.4 Erythromycin Sales Growth and Price

10.4.1 Global Erythromycin Sales Growth (2013-2018)

10.4.2 Global Erythromycin Price (2013-2018)

10.5 Fidaxomicin Sales Growth and Price

10.5.1 Global Fidaxomicin Sales Growth (2013-2018)

10.5.2 Global Fidaxomicin Price (2013-2018)

10.6 Telithromycin Sales Growth and Price

10.6.1 Global Telithromycin Sales Growth (2013-2018)

10.6.2 Global Telithromycin Price (2013-2018)

11 Global Macrolide Antibiotics Market Segment by Application

11.1 Global Macrolide Antibiotics Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Dermatology Clinics Sales Growth (2013-2018)

11.4 Pharmaceutical Companies Sales Growth (2013-2018)

12 Macrolide Antibiotics Market Forecast (2018-2023)

12.1 Global Macrolide Antibiotics Sales, Revenue and Growth Rate (2018-2023)

12.2 Macrolide Antibiotics Market Forecast by Regions (2018-2023)

12.2.1 North America Macrolide Antibiotics Market Forecast (2018-2023)

12.2.2 Europe Macrolide Antibiotics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Macrolide Antibiotics Market Forecast (2018-2023)

12.2.4 South America Macrolide Antibiotics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Macrolide Antibiotics Market Forecast (2018-2023)

12.3 Macrolide Antibiotics Market Forecast by Type (2018-2023)

12.3.1 Global Macrolide Antibiotics Sales Forecast by Type (2018-2023)

12.3.2 Global Macrolide Antibiotics Market Share Forecast by Type (2018-2023)

12.4 Macrolide Antibiotics Market Forecast by Application (2018-2023)

12.4.1 Global Macrolide Antibiotics Sales Forecast by Application (2018-2023)

12.4.2 Global Macrolide Antibiotics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Macrolide Antibiotics Picture

Table Product Specifications of Macrolide Antibiotics

Figure Global Sales Market Share of Macrolide Antibiotics by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery